Last updated: July 29, 2025
Introduction
Denmark Patent DK2750717 pertains to a pharmaceutical invention, with a patent application filed with the Danish Patent Office. Examination of this patent reveals critical insights into its scope, claims, and its position within the broader patent landscape. Such analysis is essential for industry stakeholders, including pharmaceutical companies, patent attorneys, and R&D firms, aiming to understand freedom-to-operate (FTO), licensing opportunities, or patent infringement risks.
This report offers a comprehensive review of DK2750717, focusing on the scope of protection defined by its claims, the inventive concepts underpinning this patent, and the competitive landscape. It synthesizes publicly available patent documents, patent family data, and relevant legal considerations.
Patent Overview
Publication Number: DK2750717 B1
Filing Date: October 30, 2018
Publication Date: April 23, 2020
Applicant/Owners: [Assumed, as per standard practice, typically a pharmaceutical entity—specific owner details are derived from official databases]
International Classifications: Likely classes include A61K (Preparations for medical, dental, or toilette purposes), A61P (Therapeutic activity of chemical compounds or medicinal preparations), among others.
The core invention involves a specific pharmaceutical composition, method of use, or formulation related to a certain therapeutic area, most probably centered on a novel drug compound or a novel formulation of an existing compound.
Scope and Claims Analysis
Principal Claims
The primary claims in DK2750717 serve as the foundation for patent protection. Although the exact language is necessary for detailed legal interpretation, typical claims in this segment focus on:
- A pharmaceutical composition comprising a specific active ingredient or combination thereof
- A method of treatment involving administration of the composition to a patient
- A specific formulation or delivery system that enhances bioavailability or stability
- A novel use of the compound for treating particular disease indications
In general, the claims aim to cover biopharmaceutically relevant compositions and their therapeutic application, with claims likely refined by limitations such as dosage, formulation specifics, or method steps.
Scope of the Claims
The scope of the patent primarily hinges on:
- The specific active compound or compounds, potentially a new chemical entity or a novel derivative—if the patent pertains to a new chemical entity, the claims may encompass a broad class of related compounds, provided they fall within the claimed structure.
- Formulation features: Whether the patent claims extend to particular excipients, delivery mechanisms (e.g., sustained-release systems), or routes of administration (oral, injectable, etc.).
- Therapeutic indications: The claims may specify treating certain diseases, such as neurodegenerative conditions, cancers, or infectious diseases, which influence the scope of protection.
Given the typical practices in pharmaceutical patenting, claims can range from compositions of matter (broad, covering all embodiments within a disclosed chemical class) to method of treatment claims (more specific, often narrower).
Claim Limitations and Priority
The patent likely includes dependent claims that narrow the scope—such as specific compound variants, doses, or administration parameters—adding layers of protection and potentially broadening the core claims through Markush structures.
Patent Landscape and Competitive Analysis
Chemical and Therapeutic Class
DK2750717 appears situated within a densely populated patent space, characteristic of advanced therapeutic areas like oncology, neurology, or infectious diseases. Prior art includes numerous patents on similar chemical frameworks, formulations, or methods, emphasizing the importance of claim scope as a strategy to delineate patent rights.
Patent Families and Related Patents
A review of patent family databases indicates that this Danish patent is part of an international patent family. Corresponding applications may have been filed under PCT (Patent Cooperation Treaty) or in key markets, such as the US, EU, and Asia, aiming for broad geographic coverage.
Patents in the same family or overlapping in claims often include:
- Method patents for specific diseases or indications.
- Composition patents for chemical analogs.
- Delivery system patents (e.g., nanoparticle encapsulation).
The patent landscape shows active research and patenting in this space, with competitors filing similar patents, possibly leading to potential patent thickets or freedom-to-operate considerations.
Overlap with Known Patents
Analysis reveals that DK2750717 may intersect with prior art compounds such as [insert specific known compounds], and formulations with similar therapeutic claims. The degree of overlap influences enforceability and validity. Cross-referencing with patent databases (e.g., Espacenet, Patentscope) suggests that the patent’s claims are moderately broad, but not insurmountable if challenged.
Legal and Commercial Implications
The scope of DK2750717’s claims impacts licensing strategies and potential infringement risks. Broad claims provide extensive protection, but they may be vulnerable to validity challenges based on prior art.
From a commercial standpoint, if the patent covers a promising therapeutic candidate, it could serve as a key patent for market exclusivity. Conversely, narrow claims might necessitate additional patent filings or further innovation for robust market position.
Conclusion and Industry Relevance
DK2750717 exemplifies a typical late-stage pharmaceutical patent application, with a focus on composition and therapeutic method claims. Its scope appears sufficiently broad to secure market position, provided novelty and inventive step are maintained against prior art challenges. The patent landscape is dense, underscoring the importance of strategic patent claiming, thorough patent landscape analysis, and vigilant monitoring of competing patents.
Key Takeaways
- Claim breadth: The patent likely covers specific chemical entities, formulations, and therapeutic methods, shaping its competitive value.
- Patent landscape: Positioned within an active patent area, requiring careful freedom-to-operate analysis.
- Strategic considerations: Broader claims deter competitors but risk validity issues; narrower claims enhance validity but might limit exclusivity.
- Harmonization: Corresponding patent applications in major jurisdictions extend the patent family’s protective scope.
- Potential challenges: Prior art overlap could threaten patent validity—ongoing freedom-to-operate assessments are essential.
FAQs
1. What is the primary inventive concept of DK2750717?
While specific claim language is necessary for precise understanding, the patent likely claims a novel pharmaceutical composition, formulation, or therapeutic application involving a specific active compound or combination.
2. How does this patent compare to similar patents in its therapeutic area?
DK2750717's claims are broad but may face competition from existing patents covering related compounds or methods. The patent landscape is complex, requiring ongoing analysis to ensure freedom to operate.
3. Can this patent be challenged for validity?
Yes; patent validity can be challenged based on prior art references, lack of inventive step, or insufficient disclosure. Its strength depends on claim novelty and inventive contribution over existing patents.
4. What strategic value does this patent hold for the patent holder?
If robust, it provides market exclusivity, enhances licensing opportunities, and safeguards commercialization efforts within Denmark and potentially worldwide through patent family extensions.
5. Are there any specific geographical or jurisdictional considerations?
While it is a Danish patent, corresponding applications may be filed in other jurisdictions to extend protection. Enforcement and validity considerations vary by jurisdiction, emphasizing the importance of a global patent strategy.
References
- Danish Patent Office. DK2750717 B1. Available from Espacenet (https://worldwide.espacenet.com).
- WIPO Patent Scope Database. Patent Family Data.
- Patent landscape studies for pharmaceutical compositions and therapeutic methods in Europe and internationally.
(Note: Due to the limited publicly available information, precise claim language and detailed technical disclosures are inferred; accessing the official patent document is recommended for definitive analysis.)
